TRAIL used in combination with PN significantly inhibited cell proliferation and induced apoptosis in TRAIL-resistant and TRAIL-sensitive human colorectal cancer cells (CRC) [25,91]. The gene discussed is TNFSF10; the disease is colorectal carcinoma.